PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
Demonstrate that telmisartan 80mg was at least as effective and possibly superior to ramipril
5mg & 10mg in lowering mean ambulatory DBP and SBP during the last 6 hrs of the 24-hr dosing
interval in mild-to-moderate hypertensives at the end of 8 and 14 week treatment phases.